Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Akshay Athavale, Nazila Jamshidi & Darren M. Roberts. (2020) Incomplete responses to the recommended dose of idarucizumab: a systematic review and pharmacokinetic analysis. Clinical Toxicology 58:8, pages 789-800.
Read now
Read now
Ovidiu Vornicu, Anne-Sophie Larock, Anne-Sophie Dincq, Jonathan Douxfils, Jean-Michel Dogné, François Mullier & Sarah Lessire. (2017) Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures. Expert Opinion on Biological Therapy 17:10, pages 1275-1296.
Read now
Read now
Charles V. Pollack$suffix/text()$suffix/text(), Richard Bernstein, Robert Dubiel, Paul Reilly, Fredrik Gruenenfelder, Menno V. Huisman, Chak-Wah Kam, Eva Kleine, Jerrold H. Levy, Frank W. Sellke, Thorsten Steiner, Anastasia Ustyugova & Jeffrey I. Weitz. (2017) Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study. Journal of Medical Economics 20:5, pages 435-442.
Read now
Read now
Marijke Peetermans & Peter Verhamme. (2017) Answer by the authors to the letter of Dr. Wang and colleagues, concerning our case report entitled “Idarucizumab for dabigatran overdose”. Clinical Toxicology 55:1, pages 66-66.
Read now
Read now
Josh J. Wang, Eric Villeneuve & Sophie Gosselin. (2017) Letter in response to “Idarucizumab for dabigatran overdose”. Clinical Toxicology 55:1, pages 65-65.
Read now
Read now
Articles from other publishers (20)
兼田 圭介大野 雄康宮崎 勇輔遠山 一成山田 勇井上 茂亮小谷 穣治. (2023) ダビガトラン過量服薬に対するイダルシズマブの静脈内投与：血漿中ダビガトラン濃度と血液凝固能の関連性(Intravenous idarucizumab for dabigatran overdose: association between plasma dabigatran concentration and coagulation profile). Nihon Kyukyu Igakukai Zasshi: Journal of Japanese Association for Acute Medicine 34:1, pages 6-11.
Crossref
Crossref
Maxime Delrue, Lucie Chevillard, Alain Stépanian, Alessandra Dragoni, Laurence Camoin‐Jau, Sébastien Voicu, Isabelle Malissin, Nicolas Deye, Marc Gainnier, Virginie Siguret & Bruno Mégarbane. (2022) Case series of massive direct oral anticoagulant ingestion—Treatment and pharmacokinetics data. European Journal of Clinical Investigation 52:6.
Crossref
Crossref
Jerrold H. Levy, Joanne van Ryn, Frank W. Sellke, Paul A. Reilly, Amelie Elsaesser, Stephan Glund, Jörg Kreuzer, Jeffrey I. Weitz & Charles V. Pollack. (2021) Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery. Annals of Surgery 274:3, pages e204-e211.
Crossref
Crossref
David B. Liss & Michael E. Mullins. (2021) Antithrombotic and Antiplatelet Drug Toxicity. Critical Care Clinics 37:3, pages 591-604.
Crossref
Crossref
W. Frank Peacock, James C. Grotta & Thorsten Steiner. (2019) Idarucizumab for Reversal of Dabigatran in Early/Emergency Surgeries: A Case Series. The Journal of Emergency Medicine 57:6, pages e167-e173.
Crossref
Crossref
Raúl Izaguirre Ávila, José Eduardo Bahena López, Evelyn Cortina de la Rosa & Miguel Ángel Hernández Márquez. (2019) Idarucizumab to revert the anticoagulant effect of dabigatran in traumatic acute subdural haematoma: a case report of first use in Latin America. European Heart Journal - Case Reports 3:2.
Crossref
Crossref
Adam Cuker, Allison Burnett, Darren Triller, Mark Crowther, Jack Ansell, Elizabeth M. Van Cott, Diane Wirth & Scott Kaatz. (2019) Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum. American Journal of Hematology 94:6, pages 697-709.
Crossref
Crossref
Ji Hyun Lee, Hong Euy Lim, Woo-Hyun Lim, Jinhee Ahn, Myung-Jin Cha, Junbeom Park, Ki Hong Lee, Hwan-Cheol Park, Eue-Keun Choi & Boyoung Joung. (2019) The 2018 Korean Heart Rhythm Society Practical Guidelines on the use of Non-Vitamin K-Antagonist Oral Anticoagulants: Bleeding Control and Perioperative Management. The Korean Journal of Medicine 94:1, pages 40-56.
Crossref
Crossref
Sariya Udayachalerm, Sasivimol Rattanasiri, Teeranan Angkananard, John Attia, Nakarin Sansanayudh & Ammarin Thakkinstian. (2018) The Reversal of Bleeding Caused by New Oral Anticoagulants (NOACs): A Systematic Review and Meta-Analysis. Clinical and Applied Thrombosis/Hemostasis 24:9_suppl, pages 117S-126S.
Crossref
Crossref
Jan Steffel, Peter Verhamme, Tatjana S Potpara, Pierre Albaladejo, Matthias Antz, Lien Desteghe, Karl Georg Haeusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldan-Schilling, Nigel Rowell, Peter Sinnaeve, Ronan Collins, A John Camm, Hein Heidbüchel, Gregory Y H Lip, Jeffrey Weitz, Laurent Fauchier, Deirdre Lane, Giuseppe Boriani, Andreas Goette, Roberto Keegan, Robert MacFadyen, Chern-En Chiang, Boyoung Joung & Wataru Shimizu. (2018) The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. European Heart Journal 39:16, pages 1330-1393.
Crossref
Crossref
Michael Levine, Michael C. Beuhler, Anthony Pizon, F. Lee Cantrel, Meghan B. Spyres, Frank LoVecchio, Aaron B. Skolnik & Daniel E. Brooks. (2018) Assessing Bleeding Risk in Patients With Intentional Overdoses of Novel Antiplatelet and Anticoagulant Medications. Annals of Emergency Medicine 71:3, pages 273-278.
Crossref
Crossref
Jennifer Mourafetis, Norman DoctorJr.Jr. & Simon Leung. (2018) Treatment of gastrointestinal bleeding with idarucizumab in a patient receiving dabigatran. American Journal of Health-System Pharmacy 75:4, pages 177-182.
Crossref
Crossref
Susan Shapiro, Neha Bhatnagar, Asif Khan, James Beavis & David Keeling. (2018) Idarucizumab for dabigatran overdose in a child. British Journal of Haematology 180:3, pages 457-459.
Crossref
Crossref
Y.-E. Claessens, J. Nadal & N. Beau. (2017) Perforation digestive sous anticoagulant directAcute abdominal surgery in a patient treated with direct oral anticoagulant. Annales fran?aises de m?decine d'urgence 7:3, pages 197-200.
Crossref
Crossref
Lene Rosenberg, Gustav Gerstrøm & Mads Nybo. (2017) Idarucizumab for Reversal of Dabigatran Prior to Acute Surgery: A Schematic Approach Based on a Case Report. Basic & Clinical Pharmacology & Toxicology 120:4, pages 407-410.
Crossref
Crossref
Ar. Papadopoulos, K. Papadopoulos, Ch. Balakera, Ch. Chouliaras, D. Katsaounis, E. Kefalou & P. Ioannides. (2017) Use of idarucizumab for dabigatran reversal in patients with non-valvular atrial fibrillation undergoing emergency surgical repair of strangulated femoral hernia. Hellenic Journal of Surgery 89:2, pages 117-120.
Crossref
Crossref
J. S. Chandan, T. Thomas & H. S. Baryah. (2017) Anticoagulants: Updates on idarucizumab. British Dental Journal 222:3, pages 140-141.
Crossref
Crossref
Alicia Potter DeFalco. 2017. Oral Anticoagulation Therapy. Oral Anticoagulation Therapy
295
303
.
Jean Amiral, Claire Dunois, Cédric Amiral & Jerard Seghatchian. (2016) Anti-Xa bioassays for the laboratory measurement of direct Factor Xa inhibitors in plasma, in selected patients. Transfusion and Apheresis Science 55:2, pages 249-261.
Crossref
Crossref
. (2016) Dabigatran etexilate overdose. Reactions Weekly 1615:1, pages 78-78.
Crossref
Crossref